Cerevel Therapeutics Holdings, Inc. (CERE)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
222 JACOBS STREET CAMBRIDGE, MA 02141

Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases, including Parkinson's, epilepsy, schizophrenia and substance use disorder. Headquartered in Cambridge, Mass., Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Are you looking for this stock instead?

View SEC Filings from CERE instead.

View recent insider trading info

Funds Holding CERE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CERE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RENGER JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
192,855 2022-04-13 10

PF EQUITY HOLDINGS 1 B.V.

  • 10% Owner
0 2022-03-31 1

COLES N ANTHONY CEO AND CHAIRPERSON

  • Officer
  • Director
425,772 2022-02-09 1

DIPIETRO KENNETH CHIEF HUMAN RESOURCES OFFICER

  • Officer
75,985 2022-02-09 1

CEESAY ABRAHAM PRESIDENT

  • Officer
120,310 2022-02-09 1

AKAMINE SCOTT CHIEF LEGAL OFFICER

  • Officer
58,572 2022-02-09 1

SANCHEZ RAMIRO CHIEF MEDICAL OFFICER

  • Officer
168,856 2022-02-09 1

BODENRADER MARK SEE REMARKS

  • Officer
24,800 2022-02-09 1

TREGONING KATHLEEN SEE REMARKS

  • Officer
63,321 2022-02-09 1

RIEDEL NORBERT G

  • Director
42,810 2022-01-04 1

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • Director
5,086,727 2021-08-26 2

SULZBERGER GABRIELLE

  • Director
63,894 2021-06-24 0

DEKKERS MARIJN E

  • Director
58,003 2021-06-10 0

GIORDANO DOUGLAS E.

  • Director
58,003 2021-06-10 0

GORDON CHRISTOPHER R

  • Director
  • 10% Owner
42,950 2021-06-10 0

KOPPEL ADAM

  • Director
  • 10% Owner
42,950 2021-06-10 0

BAIN CAPITAL INVESTORS LLC

BC PERCEPTION HOLDINGS, LP

BCPE PERCEPTION GP, LLC

BAIN CAPITAL FUND XII, LP

BAIN CAPITAL PARTNERS XII, LLC

  • 10% Owner
60,632,356 2020-11-09 0

AMBERGATE TRUST

LYNDA DE LOGI TRUST

SMITH DANA C

ROTHSCHILD TRUST GUERNSEY LTD (AMBERGATE)

  • 10% Owner
2,811,366 2013-01-16 0

CARLSON ROBERT W JR.

  • SEE REMARKS
No longer subject to file 2012-05-24 0

ARTAL LUXEMBOURG S A

ARTAL INTERNATIONAL SCA

ARTAL GROUP S A

WESTEND SA

STICHTING ADMINISTRATIEKANTOOR WESTEND

  • 10% Owner
4,056,935 2012-02-27 0

AMBERGATE TRUST

LYNDA DE LOGI TRUST

ROTHSCHILD TRUST GUERNSEY LTD (AMBERGATE)

CARLSON ROBERT W JR.

SMITH DANA C

  • 10% Owner
2,511,366 2012-02-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 22:15:04 UTC 2.0521 0.2679 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 21:45:03 UTC 2.0537 0.2663 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 21:15:03 UTC 2.0537 0.2663 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 20:45:04 UTC 2.0516 0.2684 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 20:15:05 UTC 2.0516 0.2684 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 19:45:04 UTC 2.0516 0.2684 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 19:15:05 UTC 2.0516 0.2684 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 18:45:04 UTC 2.052 0.268 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 18:15:03 UTC 2.052 0.268 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 17:45:04 UTC 2.052 0.268 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 17:15:04 UTC 2.052 0.268 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 16:45:05 UTC 2.0518 0.2682 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 16:15:05 UTC 2.0518 0.2682 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 15:45:04 UTC 2.0518 0.2682 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 15:15:03 UTC 2.0518 0.2682 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 14:45:04 UTC 2.0518 0.2682 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 14:15:04 UTC 2.0518 0.2682 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 13:45:05 UTC 2.0264 0.2936 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 13:15:04 UTC 2.0264 0.2936 600000
CEREVEL THERAPEUTICS HOLDING CERE 2022-08-05 12:45:05 UTC 2.0264 0.2936 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund CERE -311.0 shares, $-10888.11 2022-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CERE -900.0 shares, $-31509.0 2022-03-31 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND CERE -11523.0 shares, $-403420.23 2022-03-31 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund CERE -400.0 shares, $-11712.0 2022-04-30 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund CERE -1002.0 shares, $-29338.56 2022-04-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund CERE -1718.0 shares, $-50303.04 2022-04-30 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund CERE -3447.0 shares, $-120679.47 2022-03-31 N-PORT

Elevate your investments